Skip to main content
. 2021 Jul 23;8:619765. doi: 10.3389/fmolb.2021.619765

TABLE 4.

Univariate and multivariate analysis of clinicopathologic factors in HNSCC patients with respect to DFS.

Characteristics Cases, n (%) Univariate Multivariate
Survival time (month) p value HR (95% CI) p value
Gender
Male 64 (80.0) 45.10 ± 4.94 0.284
Female 16 (20.0) 57.19 ± 9.34
Age (years)
 <60 49 (61.3) 47.35 ± 5.67 0.891
≥60 31 (38.8) 42.65 ± 5.81
Localization
Oropharynx 17 (21.3) 42.37 ± 8.12 0.805
Non-oropharynx 63 (78.8) 47.20 ± 4.92
Histology
Well differentiated 18 (22.5) 70.94 ± 9.19 0.045 0.234
Moderately differentiated 47 (58.8) 41.35 ± 5.14
Poorly differentiated 15 (18.8) 32.20 ± 7.43
TNM stage
Ⅰ/Ⅱ 33 (41.3) 63.90 ± 6.40 0.001 0.206
Ⅲ/Ⅳ 47 (58.8) 35.92 ± 5.29
Tumor size
≤4 cm 48 (60.0) 55.91 ± 5.73 0.016 0.572
 >4 cm 32 (40.0) 34.91 ± 6.20
Lymph node metastasis
Negative (N0) 49 (61.3) 56.92 ± 5.56 0.002 2.253 (1.237–4.102) 0.008
Positive (N1-3) 31 (38.8) 31.48 ± 5.99
Tobacco smoking
Non-smoker 28 (35.0) 51.14 ± 7.55 0.640
Smoker 52 (65.0) 44.36 ± 5.18
Alcohol consumption
Non-drinker 37 (46.3) 48.32 ± 6.56 0.964
Drinker 43 (53.8) 45.48 ± 5.70
p16 status
Negative 26 (32.5) 57.75 ± 7.99 0.114
Positive 54 (67.5) 42.48 ± 5.07
TIM-3+ TILs count
Low 41 (51.3) 63.77 ± 5.85 0.000 0.094
High 39 (48.8) 29.76 ± 5.10
CEACAM1+ TILs count
Low 40 (50.0) 59.61 ± 6.17 0.011 0.753
High 40 (50.0) 35.09 ± 5.57
CEACAM1
Low 41 (51.3) 73.21 ± 5.15 0.000 7.143 (3.623–14.085) 0.000
High 39 (48.8) 20.43 ± 3.89